Shares of Novavax Inc. NVAX rallied 4.47% to $8.18 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.50% to ...
Ianalumab, for the treatment of primary immune thrombocytopenia, was granted FDA orphan designation, according to a post on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback